Abhoy Sarkar's Avatar
published in Blogs
Dec 01, 2021
Pfizer (PFE, $53.34),Biontech to seek FDA approval for booster shots

Pfizer (PFE, $53.34),Biontech to seek FDA approval for booster shots

Pfizer  and partner BioNTech  are going to seek the approval of the U.S. Food and Drug Administration possibly this week  to expand Covid-19 booster shot eligibility to 16- and 17-year-olds. Currently, 18 and older are eligible for booster shots six months after receiving the second shot of the Pfizer-BioNTech or Moderna  vaccine.

According to the Washington Post, the regulators are expected to approve on the booster shot request quickly.

Eligible people can receive the Jonson & Johnson booster shot two months after getting the single-dose vaccine.

President Joe Biden on Monday urged Americans to get vaccinated and schedule boosters, he called the shots "the best protection” against the Omicron or any of the variants.

Related Tickers: PFE